Pertussis Vaccine Market Overview

The Pertussis Vaccine Market is expected to grow at a steady pace in the coming years, driven by the increasing adoption of pertussis vaccination, rising awareness of the benefits of pertussis vaccination, and increasing prevalence of pertussis. Whooping cough is treated with a pertussis vaccine. This vaccine is only available in conjunction with other vaccines. All children, babies, teenagers, and pregnant women should get vaccinated against pertussis.

Pertussis Vaccine Market Dynamics

Pertussis, also known as whooping cough, is a serious respiratory disease that can be especially dangerous for babies and young children. The pertussis vaccine is a safe and effective way to protect yourself and your loved ones from whooping cough.

The pertussis vaccine is very effective at preventing whooping cough. Studies have shown that the pertussis vaccine can reduce the risk of whooping cough by up to 90%. The vaccine is also effective at preventing severe complications of whooping cough, such as pneumonia, seizures, and brain damage.

The pertussis vaccine can cause some side effects, but they are usually mild and go away on their own within a few days. The most common side effects are soreness, redness, and swelling at the injection site. Other possible side effects include fever, headache, tiredness, and muscle aches. Serious side effects are extremely rare.

For More Insights Download Sample

The Centers for Disease Control and Prevention (CDC) recommends that all infants, children, adolescents, and adults get vaccinated against pertussis. Infants should receive five doses of the pertussis vaccine at the ages of 2, 4, 6, 15-18 months, and 4-6 years. Children and adolescents should receive a booster dose of the pertussis vaccine at age 11-12. Adults should get a Tdap booster vaccine every 10 years.

Pertussis Vaccine Market Segment Analysis

By Product Type

By Vaccine Type

By End User

By Region

Major Companies Covered

GlaxoSmithKline, Sanofi, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc., KM Biologics

About us

DataM Intelligence 4 Market Research is a premier market research and business consulting firm that empowers businesses with accurate, reliable, and real-time market data and insights across a wide range of industries. Established in 2017, we have collaborated with over 750 companies, delivering valuable market intelligence for more than 6000 markets. Our expertise, extensive industry coverage, and robust research methodology have earned us the trust of our clients, making us their go-to partner for market intelligence needs.

At DataM Intelligence, we provide comprehensive, insightful, and actionable market intelligence, helping businesses navigate complex market landscapes and make informed decisions. Our dedicated team of analysts and industry experts possess in-depth knowledge and experience in their respective fields, ensuring the highest levels of accuracy and data integrity. Choose DataM Intelligence for all your market research and business consulting needs and experience the difference our commitment to excellence can make for your business.

Media Contact

Company Name: DataM Intelligence
Contact Person: Sonal Kumari
Email: info@datamintelligence.com
Phone:+1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/